Hepatocellular Carcinoma (HCC) accounts for about 75% of primary liver cancers. HCC begins in liver cells known as hepatocytes and most often occurs in individuals whose liver has been damaged by Hepatitis B or C virus-infection, alcohol consumption, and non-alcoholic steatohepatitis. HCC typically occurs in older people and is more common in men.
Treatment tends to be multi-modal when HCC is considered loco-regional, which often includes interventional radiology and surgical interventions. Because of the frequency of liver comorbidities in patients with HCC and the complexity of managing care using multiple modalities, a multidisciplinary approach is critical.
This report highlights effective practices in care coordination in action and provides valuable insights for cancer programs to consider. Findings from an environmental scan helped inform focus groups and interviews with three ACCC Member Programs exploring their effective practices in HCC care coordination.
Thank you to the following ACCC Cancer Program Member sites for their participation:
Presented at 2019 Society of Interventional Radiology Annual Scientific Meeting in Seattle, WA.
Presented at the 2019 ASCO Gastrointestinal Cancers Symposium in San Francisco, CA.